Trademark: BAVARIAN NORDIC 1123679
Word
BAVARIAN NORDIC
ID
1123679
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
16 September 2005
Registration Date
16 September 2005
Renewal Date
16 September 2025
Owner(s)
Service
Refer to WIPO address for Correspondence
Goods and Services:
Class 1:
Molecular vectors for gene therapy use; biochemical adjuvants to increase the efficacy/activity of vaccines and drugs; molecular antigens to induce the formation of antibodies in a cell for use in immunology research; viruses, including recombinant viruses, other than for medical or veterinary use; chemical and biochemical substances
Molecular vectors for gene therapy use; biochemical adjuvants to increase the efficacy/activity of vaccines and drugs; molecular antigens to induce the formation of antibodies in a cell for use in immunology research; viruses, including recombinant viruses, other than for medical or veterinary use; chemical and biochemical substances
Class 5:
Pharmaceutical and veterinary preparations, in particular, preparations for the treatment and prevention of infectious diseases, viral diseases, poxvirus diseases, smallpox, tumor diseases allergies; preparations for stimulating and modulating the immune system; preparations for accelerating the maturation of the immune system; preparations for the treatment and prevention of cancer, AIDS, pneumonia, bronchiolitis, respiratory diseases, Dengue fever, inflammatory diseases, including rheumatism and arthritis/neuritis, dermatological diseases, including Psoriasis and allergic skin eczema, dementia, mental retardation diseases; vaccines; vaccine vectors and drug candidates; vaccine adjuvants
Pharmaceutical and veterinary preparations, in particular, preparations for the treatment and prevention of infectious diseases, viral diseases, poxvirus diseases, smallpox, tumor diseases allergies; preparations for stimulating and modulating the immune system; preparations for accelerating the maturation of the immune system; preparations for the treatment and prevention of cancer, AIDS, pneumonia, bronchiolitis, respiratory diseases, Dengue fever, inflammatory diseases, including rheumatism and arthritis/neuritis, dermatological diseases, including Psoriasis and allergic skin eczema, dementia, mental retardation diseases; vaccines; vaccine vectors and drug candidates; vaccine adjuvants